Occult HBV reactivation induced by ibrutinib treatment: a case report.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_A5DB1D3900B6
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Production externe
Title
Occult HBV reactivation induced by ibrutinib treatment: a case report.
Journal
Acta Gastro-enterologica Belgica
Author(s)
de Jésus Ngoma P., Kabamba B., Dahlqvist G., Sempoux C., Lanthier N., Shindano T., Van Den Neste E., Horsmans Y.
ISSN
1784-3227 (Print)
ISSN-L
1784-3227
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
78
Number
4
Pages
424-426
Language
english
Notes
Publication types: Case Reports ; Journal ArticlePublication Status: ppublish
Abstract
Ibrutinib is a small molecule that has been recently developped for the treatment of B cell malignancies. Common side effects are diarrhoea, nausea, fatigue, infections, neutropenia and thrombocytopenia. Here we report the first case of Hepatitis B virus reactivation in a 80 years old chronic lymphocytic leukaemia patient receiving ibrutinib, suggesting that such treatment must be associated with HBV screening.
Keywords
Aged, 80 and over, Hepatitis B/etiology, Hepatitis B/pathology, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/complications, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Pyrazoles/adverse effects, Pyrimidines/adverse effects, Virus Activation
Pubmed
26712054
Web of science
000373452000010
Create date
20/10/2016 16:30
Last modification date
20/08/2019 16:10
Usage data